Rick Hamler

Ex Vivo and in Vivo Effects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease

Ying Sun, Benjamin Liou, Brian Quinn et al. · Journal of Biological Chemistry · 2011 · 106 citations · Full text

Life Sciences, Biochemistry, Genetics +15

A two‐dimensional liquid‐phase separation method coupled with mass spectrometry for proteomic studies of breast cancer and biomarker identification

Rick Hamler, Kan Zhu, Nathan S. Buchanan et al. · PROTEOMICS · 2004 · 93 citations

Life Sciences, Biochemistry, Molecular Biology +17

Differential Screening and Mass Mapping of Proteins from Premalignant and Cancer Cell Lines Using Nonporous Reversed-Phase HPLC Coupled with Mass Spectrometric Analysis

Bathsheba E. Chong, Rick Hamler, David M. Lubman et al. · Analytical Chemistry · 2001 · 72 citations

Life Sciences, Molecular Biology, Oncology +17

Coformulation of a Novel Human α -Galactosidase A With the Pharmacological Chaperone AT1001 Leads to Improved Substrate Reduction in Fabry Mice

Su Xu, Yi Lun, Nastry Brignol et al. · Molecular Therapy · 2015 · 37 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease

Rick Hamler, Nastry Brignol, Sean W. Clark et al. · Analytical Chemistry · 2017 · 29 citations

Life Sciences, Biochemistry, Neuroscience +17